BOLT - Bolt Biotherapeutics, Inc.
4.3
-0.050 -1.163%
Share volume: 11,312
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$4.35
-0.05
-0.01%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 03-24-2025 | 05-12-2025 | 11-12-2025 | |
| Total revenue | 0.000 | 1.222 M | 2.169 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 1.222 M | 2.169 M | |
| 77.50% | ||||
| Operating expenses | 15.669 M | 13.337 M | 9.872 M | |
| Selling general and admin | 3.947 M | 3.825 M | 3.337 M | |
| Research and development | 11.722 M | 9.512 M | 6.535 M | |
| Total expenses | 16.916 M | 13.337 M | 9.872 M | |
| -21.16% | -25.98% | |||
| Operating income | -16.916 M | -12.115 M | -7.703 M | |
| Ebit | -16.916 M | -12.093 M | -7.621 M | |
| Pretax income | -15.936 M | -11.040 M | -7.144 M | |
| -30.72% | -35.29% | |||
| Income tax | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | -15.936 M | -11.040 M | -7.144 M | |
| 30.72% | 35.29% |